Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor

28 August 2023 (15:15 - 15:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jaya Birgitte Rosenmeier

AstraZeneca, Gothenburg (Sweden)

5 More presentations in this session

Presentation thumbnail

The acute hemodynamic effects of sodium lactate infusion: increased cardiac output and decreased afterload in a randomized trial in pigs

Mr O. Horsdal (Aarhus N, DK)

Abstract Slides Video

Presentation thumbnail

Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.

Doctor K. Morikawa (Kumamoto, JP)

Abstract Slides Video

Presentation thumbnail

Therapeutic potential of pharmacological inhibition of programmed apoptosis, necroptosis, and ferroptosis in improving left ventricular function in post-myocardial infarction rats

Doctor C. Piamsiri (Chiang Mai, TH)

Abstract Slides Video

Presentation thumbnail

Effects of vericiguat on redox signaling in cardiomyocyte

Doctor T. Harada (Yufu City, JP)

Abstract Slides Video

Presentation thumbnail

Long-acting CRF2 peptide agonist improves cardiac function in a rat heart failure model

Mr Y. Stephan (Rouen, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Experimental therapies for heart failure

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources